Selective factor Xa inhibition for thromboprophylaxis

Lancet. 2008 Jul 5;372(9632):6-8. doi: 10.1016/S0140-6736(08)60879-X. Epub 2008 Jun 24.
No abstract available

Publication types

  • Comment

MeSH terms

  • Anticoagulants / pharmacology
  • Anticoagulants / therapeutic use*
  • Clinical Trials as Topic
  • Enoxaparin / pharmacology
  • Enoxaparin / therapeutic use*
  • Factor Xa Inhibitors*
  • Humans
  • Morpholines / pharmacology
  • Morpholines / therapeutic use*
  • Postoperative Complications / prevention & control*
  • Rivaroxaban
  • Thiophenes / pharmacology
  • Thiophenes / therapeutic use*
  • Venous Thromboembolism / prevention & control*

Substances

  • Anticoagulants
  • Enoxaparin
  • Factor Xa Inhibitors
  • Morpholines
  • Thiophenes
  • Rivaroxaban